Us Bancorp \De\ Lexicon Pharmaceuticals, Inc. Transaction History
Us Bancorp \De\
- $75.6 Billion
- Q4 2024
A detailed history of Us Bancorp \De\ transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,624 shares of LXRX stock, worth $1,218. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,624Holding current value
$1,218% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding LXRX
# of Institutions
143Shares Held
240MCall Options Held
459KPut Options Held
133K-
Artal Group S.A. Luxembourg, N4136MShares$102 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$29.2 Million3.05% of portfolio
-
Orbimed Advisors LLC San Diego, CA11MShares$8.27 Million0.41% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$7.42 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$7.41 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $142M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...